CVE-2025-15399: IBM Common Licensing · Cross-Site Request Forgery (CSRF)
Affects IBM Common LicensingSource CVE Database V5
Not known to be exploited · CVSS 10.0 Critical.
Data as of 2 Nov 2026, 22:57 UTC
- EPSS
- 0.2% chance of exploitation in 30 days – higher than 16% of CVEsExploit Prediction Scoring System: the likelihood attackers will use this flaw soon.
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:C/C:H/I:H/A:HExploitation evidence
Disclosed: evidence found.
CVE published 18 Sep 2026
Detectable: no evidence on record.
No public nuclei template indexed
Weaponized: no evidence on record.
No public exploit code indexed in Metasploit or Exploit-DB
Exploited in the wildExploited: no evidence on record.
Not in CISA KEV and no source reports exploitation
Observed by OffSeq MirageSeen by Mirage: no evidence on record.
No attack traffic recorded by OffSeq Mirage sensors
A missing step is not evidence of safety. Sources: cve.org (opens in a new tab), the Metasploit, Exploit-DB and nuclei-templates index as of 2 Nov 2026.
What to do
Affected software
| Product | Affected | Fixed in |
|---|---|---|
| IBMCommon Licensing | Affected
| Fixed in– |
CPE configurations (2)
cpe:2.3:a:ibm:common_licensing:agent:*:*:*:*:*:*:*cpe:2.3:a:ibm:common_licensing:art:*:*:*:*:*:*:*
AI-suggested
Until an official fix is available, users should apply any recommended temporary mitigations from IBM and avoid exposing the affected interfaces to untrusted networks or users.
Description
IBM Common Licensing Agent 9.0, Agent 9.0.0.1, Agent 9.0.0.2, ART 9.0, ART 9.0.0.1, and ART 9.0.0.2 is vulnerable to cross-site request forgery which could allow an attacker to execute malicious and unauthorized actions transmitted from a user that the website trusts.